序号 |
标题 |
次数 |
作者 |
发布时间 |
75241 |
Fmoc-G-amino-CH2O acetyl-Exetecan的化学结构,1599440-09-1 |
150 |
wyh |
2024-12-24 |
75242 |
Carboxylic Acid-Doxorubicin Liposome (PEGylated),羧酸-阿霉素脂质体(聚乙二醇化) |
171 |
axc |
2024-12-24 |
75243 |
t-Butyl acetate-PEG2-CH2COOH,CAS号:883564-93-0 |
96 |
h |
2024-12-24 |
75244 |
Azido-PEG8-CH2COO-PFP,CAS号:2182601-80-3 |
83 |
h |
2024-12-24 |
75245 |
Control Doxorubicin Liposome (PEGylated),对照阿霉素脂质体(聚乙二醇化) |
111 |
axc |
2024-12-24 |
75246 |
Azido-PEG1-CH2CO2H,CAS号:79598-48-4 |
104 |
h |
2024-12-24 |
75247 |
Propargyl-PEG4-CH2CO2-NHS,CAS号:2144777-76-2 |
89 |
h |
2024-12-24 |
75248 |
Doxorubicin Liposome (PEGylated),阿霉素脂质体(聚乙二醇化) |
873 |
axc |
2024-12-24 |
75249 |
Cbz-NH-PEG3-CH2COOH,CAS号:462100-05-6 |
108 |
h |
2024-12-24 |
75250 |
Control High Potency Clodronate Liposome (Anionic),对照高效氯膦酸盐脂质体(阴离子) |
104 |
axc |
2024-12-24 |
75251 |
Cbz-NH-PEG2-CH2COOH,CAS号:165454-06-8,8-苄氧羰基氨基-3,6-二氧杂辛酸 |
103 |
h |
2024-12-24 |
75252 |
Cbz-NH-PEG5-CH2COOH,CAS号:1449390-66-2 |
103 |
h |
2024-12-24 |
75253 |
Cbz-NH-PEG1-CH2COOH,CAS号:1260092-43-0 |
162 |
h |
2024-12-24 |
75254 |
Fmoc-NH-PEG12-CH2COOH,CAS号:2291257-76-4 |
97 |
h |
2024-12-24 |
75255 |
Boc-NH-PEG1-CH2COOH |
108 |
h |
2024-12-24 |
75256 |
Fmoc-NH-PEG11-CH2COOH,CAS号:2629308-66-1 |
72 |
h |
2024-12-24 |
75257 |
Boc-Aminooxy-PEG2-CH2COOH,CAS号:2098983-14-1 |
117 |
h |
2024-12-24 |
75258 |
11-马来酰胺基十一烷酸,11-Maleimidoundecanoic acid |
100 |
wyh |
2024-12-24 |
75259 |
Mc-Val-Cit-PABC-PNP,159857-81-5 ,抗体- 药物偶联物 |
91 |
hyy |
2024-12-24 |
75260 |
m-PEG7-(CH2)3-alcohol ,甲氧基-七聚乙二醇-三个亚甲基-乙醇 |
118 |
wyh |
2024-12-24 |
75261 |
m-PEG6-(CH2)8-phosphonic acid的化学性质,2028284-71-9 |
79 |
wyh |
2024-12-24 |
75262 |
Fmoc-amino-PEG3-CH2COOH,Fmoc-11-氨基-3,6,9-三氧杂十一酸,CAS号:139338-72-0 |
142 |
h |
2024-12-24 |
75263 |
Boc-NH-PEG2-CH2COOH,CAS号:108466-89-3,2-[2-(叔丁氧羰基氨基)乙氧基]乙氧基乙酸 |
142 |
h |
2024-12-24 |
75264 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester,甲基-六聚乙二醇-(CH2)8-膦酸乙酯 |
113 |
wyh |
2024-12-24 |
75265 |
Boc-NH-PEG3-CH2COOH,CAS号:462100-06-7,三氧杂-2-氮杂十三烷二酸-1-叔丁酯 |
112 |
h |
2024-12-24 |
75266 |
High Potency Clodronate Liposome (Anionic),高效氯膦酸盐脂质体(阴离子) |
107 |
axc |
2024-12-24 |
75267 |
Azido-PEG1-CH2COO-Cl,CAS号:79598-49-5 |
113 |
h |
2024-12-24 |
75268 |
Azido-PEG9-CH2COOH |
110 |
h |
2024-12-24 |
75269 |
Propargyl-PEG4-(CH2)3-methyl ester ,炔丙基-聚乙二醇(PEG4)-甲酯基团 |
142 |
wyh |
2024-12-24 |
75270 |
DiR Labeled Control Clodronate Liposome (Anionic),DiR标记的对照氯膦酸盐脂质体(阴离子) |
165 |
axc |
2024-12-24 |
75271 |
Azido-PEG10-CH2COOH |
89 |
h |
2024-12-24 |
75272 |
Azido-PEG11-CH2COOH,CAS号:2567584-97-6 |
118 |
h |
2024-12-24 |
75273 |
11-(马来酰亚胺基)十一烷酸琥珀酰亚胺酯 ;Maleimide-(CH2)10-COONHS; KMUS |
111 |
wyh |
2024-12-24 |
75274 |
DiD Labeled Control Clodronate Liposome (Anionic),DiD标记的对照氯膦酸盐脂质体(阴离子) |
165 |
axc |
2024-12-24 |
75275 |
Azido-PEG6-CH2COOH,CAS号:880129-82-8 |
112 |
h |
2024-12-24 |
75276 |
DBCO-NHCO-PEG2-CH2COOH |
90 |
h |
2024-12-24 |
75277 |
6-马来酰亚胺基己酸 ,Maleimide-(CH2)5-COOH |
106 |
wyh |
2024-12-24 |
75278 |
DiA Labeled Control Clodronate Liposome (Anionic),DiA标记的对照氯膦酸盐脂质体(阴离子) |
94 |
axc |
2024-12-24 |
75279 |
Br-PEG3-CH2COOH,CAS号:1346502-15-5,溴代四聚乙二醇羧酸 |
88 |
h |
2024-12-24 |
75280 |
DiI Labeled Control Clodronate Liposome (Anionic),DiI标记的对照氯膦酸盐脂质体(阴离子) |
109 |
axc |
2024-12-24 |
75281 |
Hydroxy-PEG4-CH2COOH sodium salt,CAS号:73349-20-9 |
89 |
h |
2024-12-24 |
75282 |
Mal-PEG2-CH2COOH,CAS号:173323-23-4 |
111 |
h |
2024-12-24 |
75283 |
Control Clodronate Liposome (Anionic),对照氯膦酸盐脂质体(阴离子) |
205 |
axc |
2024-12-24 |
75284 |
Clodronate Liposome (Anionic) 氯膦酸盐脂质体(阴离子) |
401 |
axc |
2024-12-24 |
75285 |
Control High Potency Clodronate Liposome (Neutral),对照高效氯膦酸盐脂质体(中性) |
113 |
axc |
2024-12-24 |